Although our study revealed that AZM could attenuate PF by inhibiting the expression of LOX and LOXL-2, the regulatory mechanisms need to be further verified (e.g. using LOX inhibitors or knockdown mice). The gene discussed is LOXL2; the disease is pemphigus foliaceus.